1357 - F-18 Fluorodeoxyglucose (FDG) positron emission tomography (PET) for the evaluation of breast cancer

Page last updated: 20 July 2016

Application Detail



Description of Medical Service

The proposed service is 18F-FDG PET scanning for the evaluation of breast cancer in patients who have locally advanced disease where other imaging does not provide sufficient information to determine appropriate treatment and in breast cancer patients where recurrent or metastatic disease is suspected and for whom active therapy is likely to be pursued.

Description of Medical Condition

Breast cancer is the most common cancer in women. In determining the best treatment for each patient, it is important to know when there is locally advanced disease, suspected recurrent breast cancer or metastatic spread. Current diagnostic methods are inferior to PET in evaluation of locally advanced disease, recurrence of disease and identification of metastatic spread. PET provides superior information to guide appropriate medical management.

Reason for Application

New MBS item

Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form


PICO Confirmation

Final Protocol (PDF 570 KB)
Final Protocol (Word 253 KB)

Assessment Report


Public Summary Document

Public Summary Document (PDF 989 KB)
Public Summary Document (Word 492 KB)

Meetings for this Application


12 to 13 December 2013
14 to 15 August 2014


8 to 10 October 2014


26 to 28 November 2014